Angelman syndrome is a rare genetic condition that affects the nervous system and development. It commonly involves intellectual disability, severe difficulty speaking, and challenges with movement and balance; seizures and sleep problems are also common. Actor Colin Farrell’s son James has the condition, according to reporting, but his experience is one person’s story—not a template for everyone with Angelman syndrome.
What is Angelman syndrome?
Angelman syndrome is a neurogenetic condition that affects development and the nervous system. Developmental differences may become noticeable between 6 and 12 months of age, although some characteristic features become clearer later. The specific abilities and support needs of each person vary.
MedlinePlus Genetics estimates that Angelman syndrome affects about 1 in 12,000 to 20,000 people; that page was updated May 17, 2022. The Angelman Syndrome Foundation gives a different measure—about one in 15,000 live births or 500,000 people worldwide—on a page accessed in 2026. These are estimates reported in different terms, not figures that can be combined into one definitive count.
What causes Angelman syndrome?
The condition is usually caused by a loss of function involving the maternal copy of the UBE3A gene in the brain. A person inherits one copy of UBE3A from each parent. In many neurons, the paternal copy is normally silenced through genomic imprinting, so the maternal copy supplies the active UBE3A. If that maternal copy is missing or does not work adequately, the brain may lack the active copy it normally relies on.
Different genetic mechanisms can disrupt maternal UBE3A activity. The mechanism matters for family counseling, but it does not by itself determine a person’s full abilities or future.
| Mechanism | What happens | Why identifying it matters |
|---|---|---|
| Maternal chromosome 15 deletion | A region of the maternal chromosome containing UBE3A is deleted. MedlinePlus describes this as the most common mechanism, at about 70% of cases. | The specific deletion and family test results inform recurrence counseling. |
| Maternal UBE3A variant | A disease-causing variant affects the maternal UBE3A gene. MedlinePlus estimates this mechanism accounts for about 10–20% of cases. | Testing can establish the variant and help clinicians assess family risk. |
| Paternal uniparental disomy | A person has two copies of chromosome 15 from the father and none from the mother. | The genetic mechanism is relevant to recurrence-risk assessment. |
| Imprinting defect | The maternal copy is present but does not have the expected active imprinting pattern. | Further genetic evaluation can help clarify the cause and inform counseling. |
| Unidentified mechanism | Some cases are not explained by currently identified mechanisms. | A negative result on particular tests does not, by itself, settle every clinical question. |
The Angelman Syndrome Foundation lists approximate subtype figures of 70% deletion, 13% mutation, 10% paternal uniparental disomy, and 7% imprinting center defect. Those figures use that foundation’s categories and rounding; they should not be merged with MedlinePlus estimates into a single distribution.
Rank #2
- Author: American Medical Association.
- Publisher: Wiley
- Pages: 1200
- Publication Date: 2004-08-01
- Edition: Fourth
What are the symptoms and support needs?
Common features include developmental delay or intellectual disability, severe expressive speech impairment, and ataxia—difficulty with movement and balance. Recurrent seizures and a smaller-than-average head size (microcephaly) are also common. Sleep difficulties can occur, and some people need monitoring or support for feeding, gastrointestinal concerns, mobility, or scoliosis.
Frequent smiling or laughter and an excitable demeanor are sometimes associated with Angelman syndrome. They are not a complete description of the condition, nor do they indicate how a person is feeling or what support they need. Spoken language may be very limited, while understanding and nonverbal communication can be stronger than speech. Not everyone has every feature, and severity varies.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →How is Angelman syndrome diagnosed?
Clinical features can prompt an evaluation, but genetic testing helps confirm the diagnosis and identify the underlying mechanism. GeneReviews, last revised May 1, 2025, reports that chromosome 15 methylation analysis detects approximately 80% of affected individuals. UBE3A sequence analysis identifies pathogenic variants in an additional approximately 11%; together, these molecular tests identify genetic alterations in approximately 90% of affected individuals. These are detection estimates, not a guarantee that testing will establish a diagnosis in every case.
Results can also guide family counseling. GeneReviews notes that most cases are simplex—one affected individual in a family—and often result from a new genetic alteration with very low recurrence risk. The risk for a particular family depends on the mechanism and parental test results, so it should be assessed with a genetics professional rather than inferred from a general estimate.
Rank #4
What care and treatment can help?
The sources cited here describe care that addresses symptoms and supports development; they do not establish a cure. A person’s plan is individualized with clinicians and may include:
- Seizure care: evaluation and treatment with an experienced clinician.
- Therapies: physical, occupational, and speech therapy to support movement, daily activities, and communication.
- Communication supports: augmentative and alternative communication (AAC), such as picture cards or communication boards, when appropriate. These can be considered with speech and communication professionals rather than treated as a universal solution.
- Ongoing monitoring: attention to sleep, behavior, feeding, reflux, constipation, mobility, and scoliosis as relevant to the individual.
GeneReviews cautions against overtreating behavior with sedating drugs and against mistaking movement abnormalities or EEG findings for uncontrolled seizures. Decisions about symptoms and medication belong with the person’s clinical team.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What is known about Colin Farrell’s son?
RTÉ reported on October 16, 2007, that Farrell had disclosed his son James had Angelman syndrome. The report quoted Farrell describing James’s first steps: “He took his first steps about six weeks ago, and it was four years in the making.” That was a dated account of one child’s development, not a typical timeline for people with the condition.
The Guardian reported on August 8, 2024, that James was diagnosed at age two and a half and that Farrell said James had previously been misdiagnosed with cerebral palsy. The article also reported Farrell’s statement, “I want the world to be kind to James,” and his wish for the world to treat his son “with kindness and respect.” Those details are attributed to the reporting, which recounted a People interview.
The Guardian described Farrell’s foundation as supporting people with intellectual disabilities and their families. Its reported remit is broader than Angelman syndrome; the article does not identify it as a specialist medical provider. James’s diagnosis and family story offer personal context, not a guide to another person’s abilities, milestones, or care.
What is the outlook?
MedlinePlus says life expectancy appears nearly normal, and the Angelman Syndrome Foundation describes it as normal. Those broad descriptions are not individual predictions: people may need lifelong care, and associated health concerns vary. GeneReviews emphasizes ongoing surveillance and care tailored to each person.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesQuick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
